Organon (OGN) Gains from Investment Securities (2021 - 2026)

Organon (OGN) has reported Gains from Investment Securities for 6 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Gains from Investment Securities changed 0.0% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at -$87.0 million (down 410.71% YoY), while the FY2025 annual figure was -$87.0 million, down 1352.16% from the prior year.
• Gains from Investment Securities came in at $1.0 million for Q1 2026 at Organon, up from -$27.0 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $41.0 million in Q4 2023, with the low at -$73.0 million in Q3 2025.
• Average Gains from Investment Securities over 5 years is -$1.8 million, with a median of $2.0 million recorded in 2024.
• Across the five-year window, Gains from Investment Securities surged 720.0% in 2023 and slumped 3750.0% in 2025, its largest moves.
• Year by year, Gains from Investment Securities stood at $5.0 million in 2022, then surged by 720.0% to $41.0 million in 2023, then plunged by 90.24% to $4.0 million in 2024, then slumped by 775.0% to -$27.0 million in 2025, then surged by 103.7% to $1.0 million in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $1.0 million, -$27.0 million, and -$73.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.